Search results for "major depressive disorder"

showing 10 items of 122 documents

Smoking Cessation in Individuals with Depression

1999

Current, historical and subclinical depression have been linked to a high incidence of cigarette smoking and smoking cessation relapse. This review discusses the efficacy, suitability and other treatment issues involved in using nicotine replacement therapy, antidepressant treatment and cognitive-behavioural interventions to help depressed smokers quit smoking. It is recommended that prior to choosing a smoking cessation treatment regimen, assessment should be made of: (i) current and past history of depression; (ii) nicotine dependency; and (iii) other risk factors (e.g. family history of depression, past difficulty in quitting) for relapse. For those individuals who are highly nicotine de…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentNicotine replacement therapymedicine.diseaseNicotinePsychiatry and Mental healthPharmacotherapymedicineAntidepressantSmoking cessationMajor depressive disorderPharmacology (medical)Neurology (clinical)Family historyPsychiatrybusinessDepression (differential diagnoses)medicine.drugCNS Drugs
researchProduct

Subtypes of Depression: Latent Class Analysis in Spanish Old People with Depressive Symptoms

2020

Major depressive disorder (MDD) is one of the most disabling disorders and the one that most contributes to disability. When it occurs in older people, it is an additional burden to their potential physical and cognitive deficiencies, making MDD an important public health problem that supposes a large investment in health. There is a clear lack of consistency between the subtypes of depression found in the literature, ranging from two to seven classes, with three being the most commonly found non-melancholic, melancholic and psychotic, or putative psychotics. The aim of this research is to add knowledge to the profiles of depressive symptoms in a representative sample of older Spanish peopl…

medicine.medical_specialtyelderlyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineQuality of life (healthcare)medicinelcsh:ScienceEcology Evolution Behavior and SystematicsDepressive symptomsDepression (differential diagnoses)major depressive disorderPublic healthPaleontologyCognitionmedicine.diseaseLatent class model030227 psychiatrySymptom profilesquality of lifeSpace and Planetary ScienceMajor depressive disorderlcsh:QErratumPsychology030217 neurology & neurosurgeryClinical psychologyLife
researchProduct

What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings

2019

Severe mental illnesses (SMI), including major depressive disorder, bipolar disorder, and schizophrenia, are associated with increased inflammation. Given diet's role in modulating inflammatory processes, excessive calorie-dense, nutrient-deficient processed food intake may contribute toward the heightened inflammation observed in SMI. This review assesses the evidence from observational and experimental studies to investigate how diet may affect physical and mental health outcomes in SMI through inflammation-related pathways. Cross-sectional studies indicate that individuals with SMI, particularly schizophrenia, consume more pro-inflammatory foods and fewer anti-inflammatory nutrients than…

medicine.medical_specialtylcsh:RC435-571Mini ReviewPopulationnutrition schizophrenia bipolar disorder nutrients vitamin03 medical and health sciences0302 clinical medicinenutrientslcsh:Psychiatrymental disordersmedicineBipolar disorderPsychiatryeducationDepression (differential diagnoses)Psychiatrybipolar disordereducation.field_of_studybusiness.industryvitaminmedicine.diseaseMental illnessMental health3. Good health030227 psychiatryschizophreniaPsychiatry and Mental healthnutritionSchizophreniaMajor depressive disorderObservational studybusiness030217 neurology & neurosurgeryFrontiers in Psychiatry
researchProduct

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care

2018

Introduction: Factors relating to the interpersonal relationship between the patient and their physician and social environment are important components, which contribute to their response to treatment for major depressive disorder. This study aimed to assess the influence of optimism, perfectionism, therapeutic alliance, empathy, social support, and adherence to medication regimen in the response to antidepressant treatments in the context of normal primary care clinical practice.Method: We conducted a prospective study in which 24 primary care physicians administered sertraline or escitalopram to 89 patients diagnosed with major depressive disorder. The response to treatment and remission…

medicine.medical_specialtylcsh:RC435-571psiquiatriaContext (language use)malalties mentals03 medical and health sciencesSocial supportprimary care0302 clinical medicinelcsh:PsychiatryInternal medicineMedicineEscitalopram030212 general & internal medicineProspective cohort studyempathyOriginal ResearchPsychiatrySertralinebusiness.industrytherapeutic alliancePrimary care physicianSocial environmentsocial supportmedicine.diseaseoptimismPsychiatry and Mental healthantidepressantsMajor depressive disorderperfectionismbusiness030217 neurology & neurosurgerymedicine.drugFrontiers in Psychiatry
researchProduct

Depression subtyping based on evolutionary psychiatry: Proximate mechanisms and ultimate functions

2018

Major depressive disorder constitutes one of the leading causes of disability worldwide. However, it is not a unitary disease-it is a heterogeneous syndrome, with patients differing remarkably in symptom profile, pathophysiology and treatment responsiveness. Previous attempts to subtype major depressive disorder have showed limited clinical applicability. We present a classification of major depressive disorder episodes based on the proximate mechanisms that led to the original mood change that caused the depressive episode. We identify discrete depression subtypes that are induced by: 1) infection, 2) long-term stress, 3) loneliness, 4) traumatic experience, 5) hierarchy conflict, 6) grief…

medicine.medical_specialtymedia_common.quotation_subjectImmunologyProinflammatory cytokine03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinemedicineHumansChronic stressPsychiatryDepression (differential diagnoses)media_commonDepressive Disorder MajorEndocrine and Autonomic SystemsLonelinessmedicine.disease030227 psychiatryAffectMoodEndogenous depressionMajor depressive disorderGriefGriefmedicine.symptomPsychology030217 neurology & neurosurgeryClinical psychologyBrain, Behavior, and Immunity
researchProduct

Mania associated with antidepressant treatment: comprehensive meta-analytic review

2009

Tondo L, Vazquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Objective:  To review available data pertaining to risk of mania–hypomania among bipolar (BPD) and major depressive disorder (MDD) patients with vs. without exposure to antidepressant drugs (ADs) and consider effects of mood stabilizers. Method:  Computerized searching yielded 73 reports (109 trials, 114 521 adult patients); 35 were suitable for random effects meta-analysis, and multivariate-regression modeling included all available trials to test for effects of trial design, AD type, and mood-stabilizer use. Results:  The overall risk of mania with/without ADs averaged …

medicine.medical_specialtymedicine.drug_classMood stabilizermedicine.diseasebehavioral disciplines and activitiesPsychiatry and Mental healthMoodMeta-analysismental disordersmedicineMajor depressive disorderAntidepressantBipolar disorderRisk factormedicine.symptomPsychiatryPsychologyManiaActa Psychiatrica Scandinavica
researchProduct

Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systemati…

2017

Early improvement of depressive symptoms during the first two weeks of antidepressant treatment has been discussed to be a resilience signal predicting a later positive treatment outcome in patients with Major Depressive Disorder (MDD). However, the predictive value of early improvement varies between studies, and the use of different antidepressants may explain heterogeneous results. The objective of this review was to assess the predictive value of early improvement on later response and remission and to identify antidepressants with the highest chance of early improvement. We included 17 randomized controlled trials investigating early improvement in 14,779 adult patients with MDD compar…

medicine.medical_specialtymedicine.drug_classmedia_common.quotation_subjectMirtazapineTricyclic antidepressantPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineOutcome Assessment Health CaremedicineHumansPsychiatryBiological Psychiatrymedia_commonDepressive Disorder MajorResilience Psychologicalmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisAntidepressantMajor depressive disorderPsychological resiliencePsychology030217 neurology & neurosurgerymedicine.drugJournal of psychiatric research
researchProduct

Influence of Transcranial Direct Current Stimulation on Psychomotor Symptoms in Major Depression

2020

Background: Transcranial direct current stimulation (tDCS) applied to the left dorsolateral prefrontal cortex (dlPFC) might be a promising treatment strategy for depression. As disturbances in psychomotor activity are one of the key features of unipolar depression are, we aimed to evaluate the behavioral effects of ten tDCS sessions over a 5-day period on psychomotor retardation in depressed patients. Methods: Twenty-three treatment-resistant depressed patients received either active or sham anodal tDCS to the left dorsolateral prefrontal cortex (2 mA, 10 sessions over 1 week). Psychomotor functioning was registered by means of observer ratings (Salp&ecirc

medicine.medical_specialtymedicine.medical_treatmentStimulationAudiologybehavioral disciplines and activitiesArticle03 medical and health sciences0302 clinical medicinepsychomotor symptomsmedicinePsychomotor learningPsychomotor functionTranscranial direct-current stimulationPsychomotor retardationmajor depressive disorderbusiness.industryGeneral NeuroscienceSmall samplemedicine.diseaseretardation030227 psychiatryMajor depressive disorderAntidepressantmedicine.symptomtranscranial direct current stimulationbusiness030217 neurology & neurosurgery
researchProduct

Treatment-resistant depression in a real-world setting: first interim analysis of characteristics, healthcare resource use, and utility values of the…

2020

Background: Major depressive disorder (MDD) is among the most common psychiatric disorders. One-third of patients are usually unresponsive to several lines of treatment. This study aimed to describe the FondaMental French cohort of patients with treatment-resistant depression (TRD) and to estimate utility and healthcare resource use outcomes. Methods: Patients with TRD were evaluated prospectively over four years (baseline, 6, 12, 18, 24, 36 and 48 months) in a real-world clinical setting. Interim analyses focused on the first two consecutive years. Four MDD-related states (major depressive episode (MDE), response, remission, recovery) were defined based on the MADRS (Montgomery&ndash

medicine.medical_specialtyreal-world[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthArticlelcsh:RC321-57103 medical and health sciences0302 clinical medicinehealthcare resource useQuality of lifeRating scaleInternal medicineMedicine[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Major depressive episodelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryDepression (differential diagnoses)business.industryGeneral Neurosciencemedicine.diseaseInterim analysis3. Good health030227 psychiatryutility[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthCohorttreatment-resistant depressionMajor depressive disorder[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessTreatment-resistant depression030217 neurology & neurosurgery
researchProduct

Motor imagery in unipolar major depression.

2014

Background: Motor imagery is a potential tool to investigate action representation, as it can provide insights into the processes of action planning and preparation. Recent studies suggest that depressed patients present specific impairment in mental rotation. The present study was designed to investigate the influence of unipolar depression on motor imagery ability. Methods: Fourteen right-handed patients meeting DSM-IV criteria for unipolar depression were compared to 14 matched healthy controls. Imagery ability was accessed by the timing correspondence between executed and imagined movements during a pointing task, involving strong spatiotemporal constraints (speed/accuracy trade-off par…

psychomotor retardationmotor imagerymajor depressive disorderspeed/accuracy trade offmovement speedmental chronometryNeuroscienceOriginal ResearchFrontiers in behavioral neuroscience
researchProduct